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ABSTRACT
Background: Refinements in percutaneous coronary inter-
vention (PCI), including the use of intravascular ultrasound 
(IVUS) and fractional flow reserve (FFR), have allowed the 
treatment of complex lesions with good results. As a result, 
the percutaneous approach for left main coronary artery (LM) 
lesions has spread, including centers with a lower volume of 
PCI procedures. Our objective was to report the early and 
late outcomes of PCI in unprotected LM lesions. Methods: 
Consecutive patients treated at two different hospitals from 
August 2009 to July 2013 were included. The indication for 
the percutaneous approach was based on the clinical assess-
ment and the calculation of Syntax score, EuroScore and on 
the patient’s wishes. Results: Twenty-eight patients with mean 
age of 69.2 ± 10.1 years were treated, 39% were diabetic 
and 39% had acute coronary syndromes. Half of the patients 
had EuroScore ≥ 6; the Syntax score was 26.0 ± 8.4 and 
82% had LM bifurcation lesions. Interventions were guided 
by IVUS and/or FFR in 71.4% of the patients, 93% were 
treated with drug-eluting stents, and the 1-stent technique was 
used in most occasions. Angiographic success was achieved 
in 100% of the cases. At the 19.2 ± 13.7 month follow-up, 
the rate of major adverse cardiac events was 21.4% in the 
follow-up longer than 4 years, cardiac death 14.2%, non-fatal 
myocardial infarction 3.5% and target-lesion revascularization 
3.5%. Conclusions: PCI in unprotected LM lesions, guided by 
IVUS and/or FFR whenever possible, is safe and effective in 
the short and long-term, in the experience of a hospital with 
a moderate number of PCI procedures.
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RESUMO
Intervenção Percutânea em Lesão de Tronco de 
Coronária Esquerda Não Protegido
Introdução: Refinamentos da intervenção coronária percutânea 
(ICP), entre eles a utilização do ultrassom intravascular (IVUS) 
e da reserva de fluxo fraccionada (FFR), têm permitido o 
tratamento de lesões complexas com bons resultados. Como 
consequência, a abordagem percutânea das lesões de TCE se 
difundiu, incluindo hospitais de menor volume de procedimentos. 
Nosso objetivo foi apresentar os resultados iniciais e tardios da 
ICP de lesões de TCE não protegido. Métodos: Foram incluídos 
pacientes consecutivos tratados em dois centros hospitalares, 
de agosto de 2009 a julho de 2013. A indicação da estratégia 
percutânea baseou-se em avaliação clínica, cálculo do escore 
Syntax, EuroScore e no desejo do paciente. Resultados: Foram 
tratados 28 pacientes, com idade de 69,2 ± 10,1 anos, 39% 
eram diabéticos e 39% eram portadores síndrome coronária 
aguda. Metade dos pacientes tinha EuroScore ≥ 6; o escore 
Syntax foi de 26,0 ± 8,4 e 82% tinham lesões localizadas 
na bifurcação. As intervenções foram guiadas por IVUS e/
ou FFR em 71,4% dos pacientes, 93% foram tratados com 
stents farmacológicos, predominantemente pela técnica de 1 
stent, e o sucesso angiográfico foi alcançado em 100% dos 
casos. O acompanhamento foi de 19,2 ± 13,7 meses. A taxa 
de desfechos clínicos maiores foi de 21,4% no seguimento 
maior a 4 anos, óbito cardíaco de 14,2%, infarto do mio-
cárdio não fatal de 3,5%, e revascularização da lesão-alvo 
em 3,5%. Conclusões: A ICP de TCE não protegido guiada, 
sempre que possível, por IVUS e/ou FFR é segura e eficaz 
no curto e longo prazos, na experiência em um hospital com 
moderado volume de procedimentos.
DESCRITORES: Doença da artéria coronariana. Estenose 
coronária. Intervenção coronária percutânea. Stents farmaco-
lógicos. Ultrassom.
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fraction, distal coronary beds unsuitable for grafts, and 
refusal of surgery by the patient. All patients signed 
an informed and free consent. The trial was approved 
by the local ethics committees.
In this trial, the inclusion criteria were patients 
with LMCA lesions ≥ 50% accompanied by symptoms 
or myocardial ischemia documented by functional test-
ing; and patients with lesions < 50% with evidence of 
ischemia documented by FFR ≤ 0.80 and/or minimal 
lumen area < 6.0 mm2 measured by IVUS. Patients with 
a history of CABG with patent grafts to the left coronary 
artery, contraindication to the use of dual antiplatelet 
therapy, and those who did not consent were excluded.
Coronary Intervention 
All patients received dual antiplatelet therapy be-
fore the procedure (initial dose: clopidogrel 600 mg 
in patients with acute coronary syndromes and 300 
mg in patients with chronic ischemia). Antithrombotic 
therapy consisted of unfractionated heparin at doses 
of 100 IU/kg for chronic cases or those with acute 
myocardial infarction, and enoxaparin at a dose of 1 
mg/kg every 12 hours for patients with coronary syn-
drome without ST-segment elevation. The selection of 
the vascular access depended on medical conditions, 
weight, age, gender, and degree of complexity of the 
coronary anatomy. Thus, the radial access was preferred 
in male patients weighing ≥ 60 kg, hemodynamically 
stable, and candidates to elective PCI. The femoral ac-
cess was generally chosen for female patients with low 
weight and complex coronary anatomy, which could 
require a guide catheter ≥ 7F.
IVUS was recommended in all cases, both for 
pre- and post-procedural assessment, and if clinically 
and technically possible. FFR was available after August 
2010 for one of the hospitals participating in this study, 
and was recommended in order to determine the treat-
ment in patients with intermediate lesions, assessed by 
angiography and IVUS; and also to assess the need for 
additional intervention to the left circumflex artery with 
the one-stent cross-over technique , from LMCA to the 
left anterior descending artery. The chosen approach 
for bifurcation lesions was that of a provisional stent, 
while the two-stent technique was restricted to patients 
who had one or more of the following characteristics in 
the left circumflex artery: severe segmental lesion at its 
origin before the intervention, severe residual stenosis 
after stent implantation, FFR < 0.80, and presence of 
dissection.
After dilation, the simultaneous kissing balloons 
(SKB) technique was performed in all cases of planned 
implantation of two stents, or with the one-stent tech-
nique if FFR < 0.80 or when there was a severe residual 
lesion in the left circumflex artery ostium. The proximal 
optimization technique with a larger-diameter balloon 
was recommended in all cases.
S ignificant lesions of the left main coronary artery (LMCA) are present in about 7 % of patients un-dergoing coronary angiography.1 In these lesions, 
percutaneous coronary intervention (PCI) may be as-
sociated with technical difficulties and, consequently, 
with high rates of major adverse cardiac outcomes.2-4 
Coronary artery bypass graft (CABG) surgery has 
always been a preferred strategy for treating patients 
with unprotected LMCA lesion, whereas PCI has been 
restricted to cases at high surgical risk. However, refine-
ments in PCI technique, the availability of drug-eluting 
stents, the use of intravascular ultrasound (IVUS), frac-
tional flow reserve (FFR), and dual antiplatelet therapy 
have contributed to significantly reduce the rates of 
stent thrombosis and restenosis. Together, these advances 
have allowed for the expansion of the indication for 
PCI to subgroups of greater complexity, such as le-
sions of the LMCA, even in patients with conditions 
requiring surgery.5,6
Several multicenter registries and some random-
ized clinical trials at centers with extensive experience 
and with highly trained surgeons have compared PCI 
and CABG surgery in LMCA lesions, demonstrating 
the safety and efficacy of the percutaneous procedure 
with use of drug-eluting stents.2-5,7 These results have 
been motivating the dissemination and application of 
the interventional strategy for selected LMCA disease 
patients in lower volume centers. 
This article presents an initial experience with 
percutaneous treatment of patients with unprotected 
LMCA lesions, showing its clinical, angiographic, and 
procedural profile, as well as its early and late results.
METHODS
Trial population
Patients undergoing PCI were prospectively included 
in a conjoined registry of Hospital José Carrasco Arteaga 
and Hospital Santa Inés, Cuenca, Ecuador. This registry 
was developed for academic quality control purposes 
and for its medicalutility. Between August 2009 and 
July 2013, 2,910 diagnostic trials and cardiovascular 
interventions by catheter were performed, of which 
672 were PCIs, and in 28 (4.1%) of these, unprotected 
LMCA lesions were assessed. The indication of percu-
taneous strategy was based on clinical assessment, in 
a SYNTAX and EuroScore score calculation, and on 
the patient’s and his/her family’s desires. In cases of 
acute coronary syndrome with ST-segment elevation 
or acute syndromes with hemodynamic instability, 
the decision for CABG was taken at the time of cine-
coronary angiography. The other cases were discussed 
with the heart team (which included a heart surgeon) 
to establish the best revascularization strategy. The 
reasons for not performing CABG included high sur-
gical risk, advanced age, low left ventricle ejection 
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Definitions and clinical outcomes 
Angiographic success was defined as a residual 
stenosis < 20% and final TIMI flow = 3. However, suc-
cessful intervention was defined as the achievement of 
angiographic success in the absence of death or stent 
thrombosis during in-hospital stay. The angiographic 
analyses were performed by an interventionist blinded 
to the results of PCIs. The quantitative parameters evalu-
ated were: minimum lumen diameter, reference vessel 
diameter, stenosis diameter, lesion length, acute gain, 
and late loss. Angiographic restenosis was defined as 
a lesion > 50% within the stent or within 5 mm from 
proximal and distal edges in relation to the stent. 
Major adverse cardiac events comprised death of 
cardiac origin, acute myocardial infarction, stroke, and 
need for target lesion revascularization. Cardiac death 
was defined as a sudden, unexplained death, or due 
to heart failure or ischemic episodes. Acute myocardial 
infarction was defined as an increase of troponin or CK-
MB ≥ 3 times the upper limit of normal, with or without 
symptoms, or as the development of new Q waves on 
the electrocardiogram in at least two contiguous leads. 
Stroke was defined as the finding of a neurological 
motor deficit, with post-intervention confirmation by 
computed tomography or magnetic resonance imag-
ing. Target lesion revascularization was defined as any 
intervention, percutaneous or surgical, performed to 
treat restenosis of the stent(s) implanted, used in turn 
to treat the LMCA lesion. Stent thrombosis was defined 
according to Academic Research Consortium (ARC). All 
patients were clinically evaluated in the clinic after 30 
days, and then every 90 days after PCI. All clinical, 
laboratory, and functional results were recorded in a 
program for digital clinical records (AS/400 system). 
A new angiography was performed with the return of 
symptoms or was suggested after six months of PCI-
index in patients with asymptomatic evolution.
Continuous variables were expressed as means 
and standard deviations and categorical variables as 
absolute numbers and percentages.
RESULTS
The population studied showed a clinical profile 
of high complexity, comprising a significant portion of 
elderly patients (39% of them > 75 years), and 39% 
of diabetics, 14% with chronic renal failure, 21% 
with peripheral vascular disease, and 39% with acute 
coronary syndrome. In 35% of cases, the left ventricle 
ejection fraction was < 45%, and 50% had EuroScores 
≥ 6 (Table 1).
The angiographic and procedural characteristics 
(Table 2 and Figures 1, 2, and 3) also revealed a com-
plex profile, with over half of patients with LMCA + 
three-vessel injuries and 82% with involvement of the 
bifurcation. The distribution of the SYNTAX score was 
39.2% for scores between 0 and 22, 42.8% for scores 
between 23 and 32, and 17.8% for scores ≥ 33. The 
procedures were performed mostly via femoral artery 
(86%), in 71% of cases with the use of one stent. 2.8 
± 1.4 stents were used per patient and 93% of patients 
received drug-eluting stents. The interventions were 
guided by IVUS and/or FFR in 71.4% of the procedures, 
and all cases achieved angiographic success.
TABLE 1 
Clinical characteristics
Characteristics n = 28
Age, years 69.2 ± 10.1
Male, n (%) 19 (67)
Diabetes mellitus, n (%) 11 (39)
Hypertension, n (%) 21 (75)
Dyslipidemia, n (%) 14 (50)
Smoking, n (%) 7 (25)
Family history of CAD, n (%) 6 (21)
Previous stroke, n (%) 1 (4)
Previous AMI, n (%) 9 (32)
Previous PCI, n (%) 8 (29)
Previous CABG surgery, n (%) 1 (4)
Chronic renal failure, n (%) 4 (14)
Peripheral vascular disease, n (%) 6 (21)
Clinical status, n (%) 
Stable angina FC II-IV 19 (76)
Unstable angina 3 (11)
AMI without ST-segment elevation 3 (11)
AMI with ST-segment elevation 5 (18)
Ejection fraction, % 50.9 ± 10.6
EuroScore 5.9 ± 3.3
Medications, n (%) 
Beta-blocker 25 (89)
ACEI or angiotensin II receptor 
inhibitor 
22 (82)
Acetylsalicylic acid 28 (100)
Clopidogrel 28 (100)
Statins 28 (100)
Inhibitors of glycoprotein IIb/IIIa 5 (18)
CAD = coronary artery disease; AMI = acute myocardial 
infarction; PCI = percutaneous coronary intervention; CABG 
= coronary artery bypass graft; FC = functional class; ACEI = 
angiotensin-converting enzyme inhibitors.
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Late angiography was performed in 12 patients, 
due to the refusal to perform a new procedure, or to 
not having reached six months of evolution after PCI 
(Table 3). Angiographic restenosis was observed in only 
one patient (3.5%). 
TABLE 2 
Angiographic and procedural characteristics 
Characteristics n = 28
Affected vessels, n (%) 
LMCA, isolated 2 (7)
LMCA + 1 vessel 5 (18)
LMCA + 2 vessels 7 (25)
LMCA + 3 vessels 14 (56)
Location of LMCA lesion, n (%) 
Ostium 3 (11)
Body 2 (7)
Bifurcation 23 (82)
Medina rating, n (%) 
1.1.1 6 (21)
1.1.0 12 (43)
1.0.0 6 (21)
0.1.0 3 (11)
0.1.1 1 (4)
Syntax score 26.0 ± 8.4
Radial approach, n (%) 4 (14)
PCI technique used, n (%) 
One stent 20 (71)
Mini-crush 4 (14)
T-stenting 2 (7)
Culotte 1 (4)
Simultaneous kissing stenting 1 (4)
Post-dilation, n (%) 
Proximal stent optimization 23 (82)
Simultaneous kissing balloons 15 (54)
Number of stents used 2.8 ± 1.4
Total length of stents, mm 58.3 ± 32.1
Drug-eluting stent, n (%) 26 (93)
First generation 6 (21)
Second generation 20 (71)
PCI guided by IVUS, n (%) 20 (71)
PCI guided by FFR, n (%) 20 (71)
Rotational atherectomy use, n (%) 4 (14)
LMCA = left main coronary artery; PCI = percutaneous coronary 
intervention; IVUS = intravascular ultrasound; FFR = fractional 
flow reserve.
Figure 1 – Lesion in the left main coronary artery (LMCA) + three 
vessels, Syntax 28. The right coronary artery was previously treated 
during an acute coronary syndrome. Lesions of LMCA and left anterior 
descending artery (LAD) were assessed by intravascular ultrasound and 
fractional flow reserve, demonstrating a need for revascularization. 
Sub-occlusive lesion in the proximal third of the left circumflex artery.
MLD = minimum lumen diameter.
????? 300°MLD 4,1 mm2
LAD LMCA
The rate of major adverse cardiac outcomes in a 
follow-up of 19.2 ± 13.7 months was 21.4% greater 
than after four years of follow-up, due the in-hospital 
cardiac death of three patients who were treated in the 
presence of an acute myocardial infarction with ST-
segment elevation, an asymptomatic acute myocardial 
infarction detected by elevation of cardiac enzymes 
three times the normal upper limit, and with a need 
for repeat revascularization due to restenosis of the 
left circumflex artery (Table 4). There were no cases 
of stroke or stent thrombosis.
DISCUSSION
PCI for the treatment of unprotected LMCA lesion, 
wherever possible guided by IVUS and FFR, is effective 
and safe in the short and long term, in the experience 
of a medical staff of a hospital with moderate proce-
dure volume.
Technical aspects
The one-stent technique was applied in most pa-
tients; two stents were used in 29% of cases. Current 
evidence suggests that the provisional T-stenting strategy 
should be preferred in bifurcation lesions, whether or 
not located in the LMCA, due to the low rate of major 
cardiac events and lower incidence of restenosis at six 
months (< 6%).8,9 In the present registry, cases with 
involvement of the bifurcation were treated with the 
simplest technique and the best clinical results were 
obtained: one stent implantation directed from the 
LMCA to the left anterior descending artery, followed 
by proximal optimization, and finally, by post-dilation 
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with SKB when necessary (guided by FFR in one-third 
of cases). A second stent was used in a smaller percent-
age of patients, which is consistent with the findings 
of several randomized trials and registries.2,4,7 However, 
there are different opinions regarding the application of 
post-dilation. Some authors have advocated the realiza-
tion of post-dilation with SKB technique in all cases 
of LMCA lesion, even when using one stent, in order 
to gain access to the lateral branch and optimize the 
proximal expansion.3-5 In the present analysis, 54% of 
patients received post-dilation with SKB, because those 
who received one stent showed no serious lesion in 
the left circumflex artery origin, dissections, changes in 
coronary flow, nor ischemia detected by FFR.
The usefulness of the SKB technique with one stent 
without involvement of the lateral branch has been 
explored in two trials on bifurcation, showing neutral 
or even harmful results.10,11 Gwon et al,10 in the COBIS 
registry, analyzed 1,065 patients with bifurcation lesions 
– two-thirds with true bifurcations. Post-dilation with 
SKB had an unfavorable effect with respect to the need 
for target lesion revascularization, probably related to a 
deformation of the rods, which was not fully corrected 
with simultaneous dilation.
Given the recent availability of FFR in this service, 
not all patients were evaluated from a functional stand-
point. However, its use has changed preconceptions 
regarding the treatment of bifurcations. For example, 
two of the cases showed LMCA lesion between 30% 
and 40%, but with abnormal values of FFR. Park et al.12 
confirmed this fact, verifying a discrepancy between 
visual estimation and functional impact of LMCA injuries. 
According to their results, 40% of lesions < 50% had 
FFR < 0.80. This discrepancy between the angiographic 
results and FFR was also a finding in the assessment of 
incarcerated lateral branch after stent implantation in 
Figure 2 – Pre-dilation of lesion in left circumflex artery bifurcation and in the proximal third, followed by rotational atherectomy for the left anterior 
descending artery. Placement of two drug-eluting stents 3.5 × 32 mm for left anterior descending artery and of 3.0 × 24 mm for left circumflex 
artery with T-stenting technique. Final post-dilation with simultaneous kissing balloons technique.
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the main branch. Koo et al.13 demonstrated that only 
27% of residual lesions ≥ 75% had FFR < 0.75 and 
needed intervention.
Since there is no other segment of the coronary 
tree with greater interobserver variability in the assess-
ment of lesion severity than the LMCA, the use of FFR 
to guide PCI can bring benefits, such as verifying the 
presence of hemodynamically significant lesions and 
the simplification of the intervention in bifurcation le-
sions.14 Considering that the presence of angiographic 
stenosis is one of the many factors that influence the 
coronary flow, the decision to intervene in an LMCA 
lesion should be based on clinical judgment, functional 
tests, and a thorough invasive evaluation, preferably by 
FFR and IVUS.
Clinical aspects
PCI for unprotected LMCA is increasingly emerging as 
a viable alternative for CABG surgery. Data collected from 
the SYNTAX trial, from numerous worldwide registries, 
and from small clinical trials have led to an evolution 
in the current indication of the European guideline for 
class IIa (level B evidence) of PCI of isolated LMCA, 
or in lesion involving the origin or body in associa-
tion with one-vessel disease. Likewise, in the opinion 
of experts, PCI has been recommended for patients at 
high surgical risk or in the setting of acute myocardial 
infarction.6 The clinical profile of the present clinical 
practice registry, measured by EuroScore and Syntax, 
showed a population with a high potential to present 
major clinical outcomes (patients with acute myocardial 
infarction, cardiogenic shock, and low ejection fraction 
were included). However, the event rate was low in the 
short and long term. This finding may be due to two fac-
tors. Firstly, the average follow-up time is relatively short, 
and there is a possibility of occurrence of a significant 
event in the. For example, in the long term. RESEARCH 
TABLE 3  
Quantitative coronary angiography 
Angiographic data n = 28
Pre-procedure 
Reference diameter, mm 3.5 ± 0.6
Minimum lumen diameter, mm 1.5 ± 0.2
Lesion length, mm 7.5 ± 2.9
Diameter of the lesion, % 57.2 ± 17.1
Post-procedure 
Reference diameter of the stent, mm 3.8 ± 0.6
Minimum diameter of the lumen of 
the stent, mm 
3.4 ± 0.6
Stent length, mm 10.1 ± 4.3
Lesion diameter in-stent, % 10.7 ± 7.1
Acute gain, mm 1.9 ± 0.8
Late n = 12
Reference diameter of the stent, mm 3.8 ± 0.4
Minimum diameter of the lumen of 
the stent, mm 
3.4 ± 0.6
Lesion diameter in-stent, % 9.4 ± 2.3
Late loss, mm –0.02 ± 0.3
Angiographic restenosis, n (%) 1 (3.5)
Figure 3 – Optimization achieved and verified by intravascular ultra-
sound through the minimal areas of the lumens in the origin of the 
left anterior descending artery (LAD), let circumflex artery (LCx), the 
polygon of confluence, and body of the left main coronary artery (LMCA). 
MLD = minimum lumen diameter; PC = polygon of confluence. 
LMCA PC
MLD 17,2 mm2 MLD 12,0 mm2
MLD 9,5 mm2 MLD 10,1 mm2
LADLCx
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registry, the subgroup of patients with unprotected LMCA 
lesion treated by PCI with drug-eluting stents and with 
high-risk clinical and angiographic profile (EuroSCORE 
= 4.2, Syntax = 39.4, and ejection fraction of 45.3%) 
presented cardiac outcomes with a significant increase in 
the second year of follow-up. The causes for this behavior 
have not been clarified.15 Second, the concomitant use 
of FFR and IVUS helped the interventionist to improve 
the cases’ selection, optimizing the immediate and 
medium-term technical and clinical results. Although 
this trial represents only the experience of a medical 
team of two centers with moderate procedure volume, 
the availability of IVUS and FFR and their application in 
two-thirds of cases may have played an important role 
in obtaining good results. Park et al.12 showed that the 
use of IVUS to optimize the intervention of unprotected 
LMCA with the use of drug-eluting stents had an impact 
on mortality, which was lower compared to PCI guided 
by angiography alone.16 The critical role of IVUS for post-
procedural assessment in a setting of LMCA is evident, 
from a trial that demonstrated a rate of restenosis < 6% 
with the two-stent technique, when the authors reached 
minimum luminal areas of 5, 6, 7, and 8 mm2 for the 
left circumflex artery origin, left anterior descending 
artery, polygon of confluence, and LMCA, respectively.17
Limitations of the study 
This was a small sample of the experience of a 
single medical staff, in addition to presenting the inherent 
limitations of an observational trial. However, it is the 
only trial of PCI in unprotected LMCA known in Brazil.
CONCLUSIONS
Guided PCI in significant lesions of unprotected 
LMCA, by IVUS and FFR whenever possible, is safe and 
effective in the medium-term follow-up, in the experience 
of a medical team with moderate procedure volume.
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